Ovcharenko, Evgeny A.Kutikhin, Anton G.Gruzdeva, OlgaKuzmina, AnastasiaSlesareva, TamaraBrusina, ElenaKudasheva, SvetlanaBondarenko, TatianaKuzmenko, SvetlanaOsyaev, Nikolay2025-11-042025-11-042023Ovcharenko E, Kutikhin A, Gruzdeva O, Kuzmina A, Slesareva T, Brusina E, et al. Cardiovascular and renal comorbidities included into neural networks predict the outcome in COVID-19 patients admitted to an intensive care unit: three-center, cross-validation, age- and sex-matched study. J Cardiovasc Dev Dis. 2023 Jan 23;10(2):39. DOI: 10.3390/jcdd100200392308-3425http://hdl.handle.net/10230/71741Here, we performed a multicenter, age- and sex-matched study to compare the efficiency of various machine learning algorithms in the prediction of COVID-19 fatal outcomes and to develop sensitive, specific, and robust artificial intelligence tools for the prompt triage of patients with severe COVID-19 in the intensive care unit setting. In a challenge against other established machine learning algorithms (decision trees, random forests, extra trees, neural networks, k-nearest neighbors, and gradient boosting: XGBoost, LightGBM, and CatBoost) and multivariate logistic regression as a reference, neural networks demonstrated the highest sensitivity, sufficient specificity, and excellent robustness. Further, neural networks based on coronary artery disease/chronic heart failure, stage 3–5 chronic kidney disease, blood urea nitrogen, and C-reactive protein as the predictors exceeded 90% sensitivity and 80% specificity, reaching AUROC of 0.866 at primary cross-validation and 0.849 at secondary cross-validation on virtual samples generated by the bootstrapping procedure. These results underscore the impact of cardiovascular and renal comorbidities in the context of thrombotic complications characteristic of severe COVID-19. As aforementioned predictors can be obtained from the case histories or are inexpensive to be measured at admission to the intensive care unit, we suggest this predictor composition is useful for the triage of critically ill COVID-19 patients.application/pdfeng© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).info:eu-repo/semantics/articlehttp://dx.doi.org/10.3390/jcdd10020039COVID-19Machine learningNeural networksPrognosticationCoronary artery diseaseChronic kidney diseaseBlood urea nitrogenC-reactive proteinLymphocyte countNeutrophil-to-lymphocyte ratioinfo:eu-repo/semantics/openAccess